Follow
SpectraCure AB
Nasdaq First North Sweden (Sweden)
SpectraCure AB develops treatment planning and laser light dose management for cancer treatment. The Company has developed its software IDOSE, and medical laser devices for the treatment.
Sector:
HEALTH CARE
>
Medical Devices
New issue
Price
16.00 SEK
Subscription period
02 Jun - 17 Jun 2020
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Show archived
Type
Ticker
ISIN
Market
SHARE
SPEC
SE0007158118
Nasdaq First North Sweden
Sweden (SE)
Details of share in SpectraCure AB with ticker SPEC
Status
Active
Order book id
4138
Amount of instruments
87 466 137
Par value
0.1000
Market cap
Currency
SEK
Segment
First North Premier
First trading date
01 Jul 2015
Terms
Type
Price
Pre-money valuation
Time
Files
IPO
2.40 SEK
39.4M SEK
25 May - 12 Jun 2015
IPO in SpectraCure AB
Market
Spotlight
Subscription period
25 May - 12 Jun 2015
Subscription price
2.40 SEK
Price per share
2.40 SEK
Target to raise
22 992 000 SEK
Types
Share issue
Pre-money valuation
39 400 000 SEK
Subscription block size
1
Minimum subscription
2 200
Record date
Offer status
Closed
Listing status
Listed
First trading date
01 Jul 2015
Issue terms
Open to the public.
Comments for offer & related information
SpectraCure will be listed on Aktietorget on June 29, 2015. The issue is guaranteed at 75 per cent.
The company issues 9 580 000 shares.
For each share allotted, there is also a free subscription option of series TO1. Two (2) warrants entitle the holder to subscribe for a one (1) new share for SEK 3.00 during the period 01 Sep - 30 Sep 2016.
Type
Price
Pre-money valuation
Time
Files
New issue
1.35 SEK
33M SEK
27 Nov 2015
Share issue in SpectraCure AB
Market
Spotlight
Subscription date
27 Nov 2015
Subscription price
Price per share
1.35 SEK
Target to raise
7 560 000 SEK
Types
Share issue
Pre-money valuation
33 000 000 SEK
Subscription block size
Minimum subscription
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Targeted to G&W Kapitalförvaltning AB with customers.
Comments for offer & related information
The subscription price is set at SEK 1.35, which means a discount of about 15% based on an average price during the last 35 trading days. The company issues 5 600 000 shares.
Type
Price
Pre-money valuation
Time
Files
Exercise
3.00 SEK
01 Sep - 30 Sep 2016
Option exercise terms for SPEC TO 1
Market
Spotlight
Exercise period(s)
01 Sep - 30 Sep 2016
Exercise price
3.00 SEK
Status
Closed
Issue terms
Two (2) subscription options (TO 1) entitles the owner to subscribe for one (1) share.
Type
Price
Pre-money valuation
Time
Files
New issue
0.80 SEK
24M SEK
02 Dec - 16 Dec 2016
Share issue in SpectraCure AB
Market
Spotlight
Subscription period
02 Dec - 16 Dec 2016
Subscription price
0.80 SEK
Price per share
0.80 SEK
Target to raise
23 989 583 SEK
Types
Share issue
Pre-money valuation
24 000 000 SEK
Subscription block size
Minimum subscription
6 000
Record date
29 Nov 2016
Offer status
Closed
Listing status
Listed
Issue terms
Rights issue. Pre-emption 1:1. Spectra Cure AB's shareholders receive one (1) unit right for each existing share. One (1) unit right is required to subscribe for one (1) unit. One unit consists of a free subscription option of series 2 (TO 2) and one share.
Comments for offer & related information
The company issues 29 986 979 shares.
Two warrants give the right to subscribe for a new share for SEK 1.00 with exercise period 31 January - 28 February 2018.
Type
Price
Pre-money valuation
Time
Files
Exercise
1.00 SEK
31 Jan - 28 Feb 2018
Option exercise terms for SPEC TO 2
Market
Spotlight
Exercise period(s)
31 Jan - 28 Feb 2018
Exercise price
1.00 SEK
Status
Closed
Issue terms
Two (2) Series 2 warrants (TO2) entitles the holder to subscribe for one (1) share in the Company.
Type
Price
Pre-money valuation
Time
Files
New issue
5.25 SEK
366.8M SEK
12 Oct - 30 Oct 2018
Share issue in SpectraCure AB
Market
Spotlight
Subscription period
12 Oct - 30 Oct 2018
Subscription price
5.25 SEK
Price per share
5.25 SEK
Target to raise
52 400 000 SEK
Types
Share issue
Pre-money valuation
366 800 000 SEK
Subscription block size
Minimum subscription
Record date
10 Oct 2018
Offer status
Closed
Listing status
Listed
Issue terms
Rights issue. Pre-emption 1:7. Seven (7) existing shares in the Company entitle to one (1) unit consisting of one (1) new share and one (1) free of charge warrants.
Comments for offer & related information
The company issues 9 976 722 units.
The new share issue is approximately 82 percent guaranteed through guarantee commitments. In the event of great interest, the issue may be increased by SEK 5.25 million.
Two (2) warrants of the TO3 series give the right to subscribe for a new share. The warrants will run through November 29, 2019 and redemption may take place during the period November 1, 2019 through November 29, 2019 at an exercise price equivalent to SEK 6.50 per share.
Type
Price
Pre-money valuation
Time
Files
Market move
04 Dec 2018
Listing of SpectraCure AB on Nasdaq First North Sweden
Move from
Spotlight
Move to
Nasdaq First North Sweden
Status
Listed
Comments for listing & related information
SpectraCure AB changed it's listing from Spotlight (previously AktieTorget) to Nasdaq First North Sweden. The first trading day for the instrument(s) on Nasdaq First North Sweden was the 4th of December 2018.
Documents
Type
Price
Pre-money valuation
Time
Files
Exercise
6.50 SEK
01 Nov - 29 Nov 2019
Option exercise terms for SPEC TO3
Former ticker
SPEC TO 3
Market
Nasdaq First North Sweden
Exercise period(s)
01 Nov - 29 Nov 2019
Exercise price
6.50 SEK
Status
Closed
Issue terms
Two (2) warrants entitles the holder to subscribe for one (1) new share.
Type
Price
Pre-money valuation
Time
Files
New issue
16.00 SEK
1.4B SEK
02 Jun - 17 Jun 2020
Share issue in SpectraCure AB
Market
Nasdaq First North Sweden
Subscription period
02 Jun - 17 Jun 2020
Subscription price
16.00 SEK
Price per share
16.00 SEK
Target to raise
140 000 000 SEK
Types
Share issue
Pre-money valuation
1 400 000 000 SEK
Subscription block size
Minimum subscription
Record date
29 May 2020
Offer status
Upcoming
Listing status
Listed
Issue terms
Rights issue. Pre-emption 1:10. Shareholders have the right to subscribe for one (1) Unit per ten (10) existing shares. One (1) unit consists of one (1) share and one (1) subscription option of series TO4.
Comments for offer & related information
The company issues 8 746 613 units. The rights issue is pre-secured up to approximately 82.5 per cent, consisting of subscription commitments corresponding to approximately 5 per cent of the Rights Issue from MK Capital AB (controlled by CEO Masoud Khayyami) and Cardeon Futuring Financing AB (owned by approximately 30 per cent by CEO Masoud Khayyami) and guarantee commitments from a number of external investors, corresponding to approximately 77.5 percent of the Rights Issue.
Two (2) warrants of the TO4 series give during the period from 1 September 2021 to 30 September 2021 the right to subscribe for one (1) new share in SpectraCure at a price of SEK 20.75 per share.
Update (28.05.2020): New share issue contains a maximum of 2,609,750 shares and a maximum of 2,609,750 warrants.

Type
Ticker
ISIN
Market
OPTION
SPEC TO4
Nasdaq First North Sweden
Sweden (SE)
Details of option in SpectraCure AB with ticker SPEC TO4
Status
Inactive
Order book id
Amount of instruments
Market cap
Currency
SEK
First trading date
Terms
Two (2) warrants of the TO4 series give during the period from 1 September 2021 to 30 September 2021 the right to subscribe for one (1) new share in SpectraCure at a price of SEK 20.75 per share.
Type
Price
Pre-money valuation
Time
Files
Exercise
20.75 SEK
01 Sep - 30 Sep 2021
Option exercise terms for SPEC TO4
Market
Nasdaq First North Sweden
Exercise period(s)
01 Sep - 30 Sep 2021
Exercise price
20.75 SEK
Status
Upcoming
Issue terms
Two (2) warrants of the TO4 series give during the period from 1 September 2021 to 30 September 2021 the right to subscribe for one (1) new share in SpectraCure at a price of SEK 20.75 per share.
Type
Ticker
ISIN
Market
SHARE
SPEC
SE0007158118
Nasdaq First North Sweden
Sweden (SE)
Details of share in SpectraCure AB with ticker SPEC
Status
Active
Order book id
4138
Amount of instruments
87 466 137
Par value
0.1000
Market cap
Currency
SEK
Segment
First North Premier
First trading date
01 Jul 2015
Terms
Type
Price
Pre-money valuation
Time
Files
IPO
2.40 SEK
39.4M SEK
25 May - 12 Jun 2015
IPO in SpectraCure AB
Market
Spotlight
Subscription period
25 May - 12 Jun 2015
Subscription price
2.40 SEK
Price per share
2.40 SEK
Target to raise
22 992 000 SEK
Types
Share issue
Pre-money valuation
39 400 000 SEK
Subscription block size
1
Minimum subscription
2 200
Record date
Offer status
Closed
Listing status
Listed
First trading date
01 Jul 2015
Issue terms
Open to the public.
Comments for offer & related information
SpectraCure will be listed on Aktietorget on June 29, 2015. The issue is guaranteed at 75 per cent.
The company issues 9 580 000 shares.
For each share allotted, there is also a free subscription option of series TO1. Two (2) warrants entitle the holder to subscribe for a one (1) new share for SEK 3.00 during the period 01 Sep - 30 Sep 2016.
Type
Price
Pre-money valuation
Time
Files
New issue
1.35 SEK
33M SEK
27 Nov 2015
Share issue in SpectraCure AB
Market
Spotlight
Subscription date
27 Nov 2015
Subscription price
Price per share
1.35 SEK
Target to raise
7 560 000 SEK
Types
Share issue
Pre-money valuation
33 000 000 SEK
Subscription block size
Minimum subscription
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Targeted to G&W Kapitalförvaltning AB with customers.
Comments for offer & related information
The subscription price is set at SEK 1.35, which means a discount of about 15% based on an average price during the last 35 trading days. The company issues 5 600 000 shares.
Type
Price
Pre-money valuation
Time
Files
New issue
0.80 SEK
24M SEK
02 Dec - 16 Dec 2016
Share issue in SpectraCure AB
Market
Spotlight
Subscription period
02 Dec - 16 Dec 2016
Subscription price
0.80 SEK
Price per share
0.80 SEK
Target to raise
23 989 583 SEK
Types
Share issue
Pre-money valuation
24 000 000 SEK
Subscription block size
Minimum subscription
6 000
Record date
29 Nov 2016
Offer status
Closed
Listing status
Listed
Issue terms
Rights issue. Pre-emption 1:1. Spectra Cure AB's shareholders receive one (1) unit right for each existing share. One (1) unit right is required to subscribe for one (1) unit. One unit consists of a free subscription option of series 2 (TO 2) and one share.
Comments for offer & related information
The company issues 29 986 979 shares.
Two warrants give the right to subscribe for a new share for SEK 1.00 with exercise period 31 January - 28 February 2018.
Type
Price
Pre-money valuation
Time
Files
New issue
5.25 SEK
366.8M SEK
12 Oct - 30 Oct 2018
Share issue in SpectraCure AB
Market
Spotlight
Subscription period
12 Oct - 30 Oct 2018
Subscription price
5.25 SEK
Price per share
5.25 SEK
Target to raise
52 400 000 SEK
Types
Share issue
Pre-money valuation
366 800 000 SEK
Subscription block size
Minimum subscription
Record date
10 Oct 2018
Offer status
Closed
Listing status
Listed
Issue terms
Rights issue. Pre-emption 1:7. Seven (7) existing shares in the Company entitle to one (1) unit consisting of one (1) new share and one (1) free of charge warrants.
Comments for offer & related information
The company issues 9 976 722 units.
The new share issue is approximately 82 percent guaranteed through guarantee commitments. In the event of great interest, the issue may be increased by SEK 5.25 million.
Two (2) warrants of the TO3 series give the right to subscribe for a new share. The warrants will run through November 29, 2019 and redemption may take place during the period November 1, 2019 through November 29, 2019 at an exercise price equivalent to SEK 6.50 per share.
Type
Price
Pre-money valuation
Time
Files
Market move
04 Dec 2018
Listing of SpectraCure AB on Nasdaq First North Sweden
Move from
Spotlight
Move to
Nasdaq First North Sweden
Status
Listed
Comments for listing & related information
SpectraCure AB changed it's listing from Spotlight (previously AktieTorget) to Nasdaq First North Sweden. The first trading day for the instrument(s) on Nasdaq First North Sweden was the 4th of December 2018.
Documents
Type
Price
Pre-money valuation
Time
Files
New issue
16.00 SEK
1.4B SEK
02 Jun - 17 Jun 2020
Share issue in SpectraCure AB
Market
Nasdaq First North Sweden
Subscription period
02 Jun - 17 Jun 2020
Subscription price
16.00 SEK
Price per share
16.00 SEK
Target to raise
140 000 000 SEK
Types
Share issue
Pre-money valuation
1 400 000 000 SEK
Subscription block size
Minimum subscription
Record date
29 May 2020
Offer status
Upcoming
Listing status
Listed
Issue terms
Rights issue. Pre-emption 1:10. Shareholders have the right to subscribe for one (1) Unit per ten (10) existing shares. One (1) unit consists of one (1) share and one (1) subscription option of series TO4.
Comments for offer & related information
The company issues 8 746 613 units. The rights issue is pre-secured up to approximately 82.5 per cent, consisting of subscription commitments corresponding to approximately 5 per cent of the Rights Issue from MK Capital AB (controlled by CEO Masoud Khayyami) and Cardeon Futuring Financing AB (owned by approximately 30 per cent by CEO Masoud Khayyami) and guarantee commitments from a number of external investors, corresponding to approximately 77.5 percent of the Rights Issue.
Two (2) warrants of the TO4 series give during the period from 1 September 2021 to 30 September 2021 the right to subscribe for one (1) new share in SpectraCure at a price of SEK 20.75 per share.
Update (28.05.2020): New share issue contains a maximum of 2,609,750 shares and a maximum of 2,609,750 warrants.

Type
Ticker
ISIN
Market
OPTION
SPEC TO 1
SE0007158126
Nasdaq First North Sweden
Sweden (SE)
Details of option in SpectraCure AB with ticker SPEC TO 1
Status
Archived
Order book id
Amount of instruments
Market cap
Currency
SEK
Trading period
29 Jun 2015 - 28 Sep 2016
Terms
Two (2) subscription options (TO 1) entitles the owner to subscribe for one (1) share.
Type
Price
Pre-money valuation
Time
Files
Exercise
3.00 SEK
01 Sep - 30 Sep 2016
Option exercise terms for SPEC TO 1
Market
Spotlight
Exercise period(s)
01 Sep - 30 Sep 2016
Exercise price
3.00 SEK
Status
Closed
Issue terms
Two (2) subscription options (TO 1) entitles the owner to subscribe for one (1) share.
Type
Ticker
ISIN
Market
OPTION
SPEC TO 2
SE0009294853
Nasdaq First North Sweden
Sweden (SE)
Details of option in SpectraCure AB with ticker SPEC TO 2
Status
Archived
Order book id
Amount of instruments
Market cap
Currency
SEK
Trading period
27 Jan 2017 - 26 Feb 2018
Terms
Two (2) Series 2 warrants (TO2) entitles the holder to subscribe for one (1) share in the Company.
Type
Price
Pre-money valuation
Time
Files
Exercise
1.00 SEK
31 Jan - 28 Feb 2018
Option exercise terms for SPEC TO 2
Market
Spotlight
Exercise period(s)
31 Jan - 28 Feb 2018
Exercise price
1.00 SEK
Status
Closed
Issue terms
Two (2) Series 2 warrants (TO2) entitles the holder to subscribe for one (1) share in the Company.
Type
Ticker
ISIN
Market
OPTION
SPEC TO3
SE0011762350
Nasdaq First North Sweden
Sweden (SE)
Details of option in SpectraCure AB with ticker SPEC TO3
Status
Archived
Order book id
164588
Amount of instruments
11 799 770
Market cap
Currency
SEK
Segment
First North Premier
Trading period
05 Dec 2018 - 27 Nov 2019
Terms
Two (2) warrants entitles the holder to subscribe for one (1) new share.
Type
Price
Pre-money valuation
Time
Files
Exercise
6.50 SEK
01 Nov - 29 Nov 2019
Option exercise terms for SPEC TO3
Former ticker
SPEC TO 3
Market
Nasdaq First North Sweden
Exercise period(s)
01 Nov - 29 Nov 2019
Exercise price
6.50 SEK
Status
Closed
Issue terms
Two (2) warrants entitles the holder to subscribe for one (1) new share.
Type
Ticker
ISIN
Market
OPTION
SPEC TO4
Nasdaq First North Sweden
Sweden (SE)
Details of option in SpectraCure AB with ticker SPEC TO4
Status
Inactive
Order book id
Amount of instruments
Market cap
Currency
SEK
First trading date
Terms
Two (2) warrants of the TO4 series give during the period from 1 September 2021 to 30 September 2021 the right to subscribe for one (1) new share in SpectraCure at a price of SEK 20.75 per share.
Type
Price
Pre-money valuation
Time
Files
Exercise
20.75 SEK
01 Sep - 30 Sep 2021
Option exercise terms for SPEC TO4
Market
Nasdaq First North Sweden
Exercise period(s)
01 Sep - 30 Sep 2021
Exercise price
20.75 SEK
Status
Upcoming
Issue terms
Two (2) warrants of the TO4 series give during the period from 1 September 2021 to 30 September 2021 the right to subscribe for one (1) new share in SpectraCure at a price of SEK 20.75 per share.
People
Number of Employees
12 people
Masoud Khayyami
CEO
Ingemar Kihlström
Chairman of the board
Stefan Andersson Engels
Board member
Masoud Khayyami
Board member
Ingemar Kihlström
Board member
Katarina Svanberg
Board member
Sune Svanberg
Board member
Hans Bornefalk
Board member
Company Details
Sector
HEALTH CARE

Address
Gasverksgatan 1
Zip code
222 29
City/district
Lund
Country
Sweden (SE)
Phones
Registration number
556642-1011
LEI code
549300U3BMSZ5VGYC283
First trade date
29 Jun 2015
Registration date
08 Oct 2017
Short name
SpectraCure

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More

Create Your FREE Account to stay Up To Date